3 facts to know about Boston Scientific’s 2018 Q2 growth

Boston Scientific released its sales and profit growth results for the second quarter of 2018.

Here are three important facts:

1. Endoscopy profits were $442 million, up from $400 million over the same period in in 2017.

2. Second quarter sales were $2.490 billion, an increase of 10.3 percent on a reported basis , 8.6 percent on an operational basis and 7.9 percent on an organic basis, compared to the prior year.

3. The company reported GAAP earnings of $555 million or $0.40 per share, compared to GAAP earnings of $146 million or $0.11 last year, and achieved adjusted earnings per share of $0.41, compared to $0.32 last year.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast